Tuesday - December 09, 2025

From Betrayal to Empowerment: Haleh Shahrzad’s Forever, Now Explores the Dark Reality of Narcissistic Abuse and the Powerful Journey of Trust, Resilience, and Reclaiming One’s Life

In Forever, Now, bestselling author Haleh Shahrzad explores the pain of being in a narcissistic and controlling relationship and transforms it into a powerful story of resilience, showing how trusting your instincts and choosing courage over fear, can lead to … Continue reading

Diffuse Large B-cell Lymphoma Market Set to Grow Substantially Through 2034, DelveInsight Projects | Genmab and AbbVie, Kite (Gilead Sciences), Denovo Biopharma, Merck

The Key Diffuse Large B-cell Lymphoma Companies in the market include – Ubix Therapeutics, Otsuka Pharmaceutical Co., Ltd, Biomea Fusion Inc, Autolus Limited, Xynomic Pharmaceuticals, Inc., Hanmi Pharmaceutical, S IMV Inc. Seagen Inc., Zai Lab, Genentech, and others. DelveInsight’s “Diffuse … Continue reading

Malignant Pleural Effusion Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Genelux Corporation, RS Oncology, Canderl Therapeutics, Abnoba Korea, Jiangsu

The Key Malignant Pleural Effusion Companies in the market include – Genelux Corporation, RS Oncology, Canderl Therapeutics, Abnoba Korea, Jiangsu Simcere Pharmaceutical, Novartis, and others. DelveInsight’s “Malignant Pleural Effusion Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding … Continue reading

Essential Thrombocythemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Jubilant Therapeutics, Kartos Therapeutics, Imago BioSciences, MorphoSys AG, PharmaEssenti

The Key Essential Thrombocythemia Companies in the market include – Jubilant Therapeutics Inc, Kartos Therapeutics, Inc, Imago BioSciences,Inc., MorphoSys AG, PharmaEssentia Corporation, Incyte Corporation, Karyopharm Therapeutics Inc, Novartis, PharmaEssentia, CTI BioPharma, Celgene, NS Pharma, Inc., Kartos Therapeutics, Inc., Sierra Oncology … Continue reading

Myelofibrosis Market to Expand Significantly by 2034, States DelveInsight Report | Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Keros Therapeutics

The Key Myelofibrosis Companies in the market include – Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others. DelveInsight’s “Myelofibrosis Market … Continue reading